Literature DB >> 22136758

Development and characterization of 5 canine B-cell lymphoma cell lines.

Allison L Zwingenberger1, William Vernau, Changying Shi, Wensheng Yan, Xinbin Chen, Ira K Gordon, Michael S Kent.   

Abstract

Canine and human lymphoma share similar characteristics in disease development and response to therapy. Translational research can be furthered using tools such as canine cell lines to model therapeutic compounds and strategies. We developed 5 B-cell lymphoma cell lines from dogs with confirmed large B-cell lymphoma. These cell lines were CD3, CD18, CD20, and CD90 positive with variable CD79a, CD1c and CD34 expression. All cell lines were tumorigenic in Nu/nu mice and were wild type for p53. Canine lymphoma cell lines serve as an important resource for translational lymphoma research. Copyright Â
© 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22136758      PMCID： PMC5404115          DOI： 10.1016/j.leukres.2011.11.004

Source DB:  PubMed          Journal:  Leuk Res        ISSN： 0145-2126            Impact factor:   3.156


  21 in total

1.  Proteolytic cleavage of the mdm2 oncoprotein during apoptosis.

Authors:  L Chen; V Marechal; J Moreau; A J Levine; J Chen
Journal:  J Biol Chem       Date:  1997-09-05       Impact factor: 5.157

Review 2.  Blinded by the Light: The Growing Complexity of p53.

Authors:  Karen H Vousden; Carol Prives
Journal:  Cell       Date:  2009-05-01       Impact factor: 41.582

3.  An immunophenotypic study of canine leukemias and preliminary assessment of clonality by polymerase chain reaction.

Authors:  W Vernau; P F Moore
Journal:  Vet Immunol Immunopathol       Date:  1999-08-02       Impact factor: 2.046

4.  DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways.

Authors:  W G Nelson; M B Kastan
Journal:  Mol Cell Biol       Date:  1994-03       Impact factor: 4.272

5.  Combinatorial chemistry identifies high-affinity peptidomimetics against alpha4beta1 integrin for in vivo tumor imaging.

Authors:  Li Peng; Ruiwu Liu; Jan Marik; Xiaobing Wang; Yoshikazu Takada; Kit S Lam
Journal:  Nat Chem Biol       Date:  2006-06-11       Impact factor: 15.040

6.  Canine indolent nodular lymphoma.

Authors:  V E Valli; W Vernau; L-P de Lorimier; P S Graham; P F Moore
Journal:  Vet Pathol       Date:  2006-05       Impact factor: 2.221

Review 7.  Dog models of naturally occurring cancer.

Authors:  Jennie L Rowell; Donna O McCarthy; Carlos E Alvarez
Journal:  Trends Mol Med       Date:  2011-03-24       Impact factor: 11.951

8.  The dog genome: survey sequencing and comparative analysis.

Authors:  Ewen F Kirkness; Vineet Bafna; Aaron L Halpern; Samuel Levy; Karin Remington; Douglas B Rusch; Arthur L Delcher; Mihai Pop; Wei Wang; Claire M Fraser; J Craig Venter
Journal:  Science       Date:  2003-09-26       Impact factor: 47.728

Review 9.  Spontaneous and genetically engineered animal models; use in preclinical cancer drug development.

Authors:  K Hansen; C Khanna
Journal:  Eur J Cancer       Date:  2004-04       Impact factor: 9.162

10.  p53, through p21 (WAF1/CIP1), induces cyclin D1 synthesis.

Authors:  X Chen; J Bargonetti; C Prives
Journal:  Cancer Res       Date:  1995-10-01       Impact factor: 12.701
View more
  4 in total

1.  Patient characteristics, prognostic factors and outcome of dogs with high-grade primary mediastinal lymphoma.

Authors:  E L Moore; W Vernau; R B Rebhun; K A Skorupski; J H Burton
Journal:  Vet Comp Oncol       Date:  2017-06-28       Impact factor: 2.613

2.  Affinity of the alpha4-beta1 integrin-targeting peptide LLP2A to canine lymphoma.

Authors:  Allison L Zwingenberger; Michael S Kent; Changying Shi; Sandra L Taylor; Xiucui Chen; Kit S Lam
Journal:  Vet Immunol Immunopathol       Date:  2011-11-25       Impact factor: 2.046

Review 3.  Beyond tradition and convention: benefits of non-traditional model organisms in cancer research.

Authors:  Rebecca M Harman; Sanjna P Das; Arianna P Bartlett; Gat Rauner; Leanne R Donahue; Gerlinde R Van de Walle
Journal:  Cancer Metastasis Rev       Date:  2020-10-28       Impact factor: 9.264

4.  Comprehensive genomic characterization of five canine lymphoid tumor cell lines.

Authors:  Sarah C Roode; Daniel Rotroff; Kristy L Richards; Peter Moore; Alison Motsinger-Reif; Yasuhiko Okamura; Takuya Mizuno; Hajime Tsujimoto; Steven E Suter; Matthew Breen
Journal:  BMC Vet Res       Date:  2016-09-17       Impact factor: 2.741
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.